Fast Track Drugs and Biologics LLC   Report issue

For profit Phase 2
Founded: North Potomac MD United States (2003)

Organization Overview

First Clinical Trial
2010
NCT01050907
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

miltefosine (impavido) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leishmaniasis (Phase 2)

Leishmaniasis, Cutaneous (Phase 2)

Leishmaniasis, Mucocutaneous (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1